Quanterix’ Simoa Technology to Support Myriad RBM’s New Immunoassay Services

Business News
Print
LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix today announced that Myriad RBM will use Quanterix’ Simoa technology to launch new ultrasensitive immunoassay services in its CLIA-certified laboratory in Austin, Texas.

imageimage
image

Read more